This article explores the emergence of subjectivity in ICH Q9 (R1).
Martin J. Lipa
Advertisement
Martin J. Lipa, PhD, [email protected], is a senior research fellow at Pharmaceutical Regulatory Science Team.
Articles by Martin J. Lipa
Recent research and perspectives shed light on an opportunity to better connect risk and knowledge through improved integration of systems.
Recent research and perspectives shed light on an opportunity to better connect risk and knowledge through improved integration of systems.
Advertisement
Latest Updated Articles
Knowledge as the Currency of Managing RiskJanuary 15th 2024
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Hold Times in Biopharmaceuticals
2
FDA Updates Master Protocol: What Developers Need to Know
3
FDA Approves Pfizer’s Breast Cancer Treatment
4
Merck KGaA Launches Saturnus Bio; Announces Awards
5